Andrew Wilkey
Physician Assistant · Calhoun, GANPI 1356054936
Payments from drug & device makers
Across 157 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$849
- Axsome Therapeutics, Inc.$702
- Jazz Pharmaceuticals Inc.$383
- Inspire Medical Systems, Inc.$304
- Novo Nordisk$174
- AbbVie$168
- plus $581 from 12 others
What the payments were for
- Food & beverage$3,11599%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 61 | $849 |
| Axsome Therapeutics, Inc. | 27 | $702 |
| Jazz Pharmaceuticals Inc. | 11 | $383 |
| Inspire Medical Systems, Inc. | 11 | $304 |
| Novo Nordisk | 9 | $174 |
| AbbVie | 13 | $168 |
| Fisher & Paykel Healthcare Inc | 3 | $106 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $83 |
| Exact Sciences | 4 | $76 |
| Lilly USA, LLC | 4 | $73 |
| Merck | 3 | $59 |
| Pfizer | 2 | $44 |
| 3b Medical, Inc. | 1 | $44 |
| Resmed Corp | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,161 in reported general payments places this provider in the 85th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 28 | $231,199 |
| XywavSodium,calcium,mag,pot Oxybate | 13 | $230,788 |
| SunosiSolriamfetol Hcl | 21 | $35,531 |
| BelsomraSuvorexant | 21 | $9,825 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 33 | $1,761 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 52 | $1,470 |
| Armodafinil | 30 | $1,156 |
| Modafinil | 15 | $1,003 |
| Eszopiclone | 23 | $295 |
| Zolpidem Tartrate | 21 | $86 |
| Clonazepam | 15 | $42 |
| Gabapentin | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $849 | $231,19928 claims |
| Axsome Therapeutics, Inc.Sunosi | $702 | $35,53121 claims |
| MerckBelsomra | $59 | $9,82521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Calhoun
- Joseph LangshawCalhoun$887K
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.